Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UnitedHealth Cancer Care Pilot Reduced Overall Costs Despite Higher Drug Spending

This article was originally published in The Pink Sheet Daily

Executive Summary

The bundled payment pilot program resulted in a 34% decrease in overall cancer treatment costs among participating medical centers despite a 179% increase in drug spending, according to results released July 8.

You may also be interested in...

UnitedHealth Moving, Slowly, Toward More Value-Based Drug Contracts

Insurer plans to execute more value-based contracts in next two years, but they will be pilot projects layered on top of existing rebate contracts.

Aetna Cancer Pathways Program Aims For 'Value-Based' Prescribing

“For many malignancies, there is no ‘best treatment’ but there may be tremendous differences in cost,” Aetna National Medical Director, Oncology Solutions Michael Kolodziej says.

Biosimilars Add “Urgency” To Medicare Payment Reforms – MedPAC Commissioner

Developing alternatives to the ASP-based reimbursement system for Medicare Part B drugs may become increasingly important to ensure the program will benefit from lower-cost biosimilars, Georgetown’s Jack Hoadley points out.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts